XML 41 R5.htm IDEA: XBRL DOCUMENT v3.20.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Cash flow from operating activities    
Net loss $ (3,324) $ (1,512)
Adjustments to reconcile net loss to net cash used in operating activities    
Stock-based compensation 170 157
Amortization of right of use assets 19 28
Depreciation 18 66
(Increase) decrease in operating assets    
Prepaid drug product for testing 12 (95)
Other current assets 250 (570)
Increase (decrease) in operating liabilities    
Accounts payable and accrued expenses 341 (54)
Lease liabilities (21) (28)
Net cash used in operating activities (2,535) (2,008)
Cash flow from financing activities    
Net proceeds from sale of common stock 0 19,411
Net proceeds from exercise of warrants 0 869
Net cash provided by financing activities 0 20,280
Net increase (decrease) in cash (2,535) 18,272
Cash, beginning of period 20,426 1,004
Cash, end of period $ 17,891 $ 19,276